Articles > Popular publications > PR Newswire press releases > January-March 2009 > Thursday, January 15

Article: Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP.

Article from:
PR Newswire
Article date:
January 15, 2009
Copyright

- Single Injection in Primates Containing 1,000-Times the Dosage Recommended for Humans Shows No Adverse Effects -

- Half-Life and AUC Support the Potential for Weekly or Bi-Monthly Dosing Frequency -

NES-ZIONA, Israel, Jan. 15 /PRNewswire-FirstCall/ -- Modigene Inc. (OTC Bulletin Board: MODG) today reported results from a pilot toxicity study in primates designed to assess the safety of hGH-CTP, its long-acting human growth hormone (hGH), as well as to provide preliminary information on the approximate injection frequency that will be needed in human patients. The study was designed to elicit potential adverse effects from a single, very large dose of ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Modigene Announces Positive Results of Pilot Toxicity Study of ...
Biotech Week;  January 28, 2009 ;     700+ words ... ... safety of hGH-CTP, its long-acting human growth hormone (hGH), as ... injection of hGH-CTP containing a ... daily dose of growth hormone recommended ... complete the hGH-CTP Phase I clinical ... Hormones, Human Growth Hormone, Therapy ...

Article: Modigene Platform Validated in Independent Phase III Trial of ...
PR Newswire;  July 10, 2008 ;     700+ words ... ... applying the CTP technology to ... action of human growth hormone and interferon ... Modigene's CTP-enhanced versions of human growth hormone and interferon ... sales. The CTP technology is ... versions of human growth hormone, interferon ...

Article: Key Trials of Organon's Long-Acting Fertility Drug Using ...
PR Newswire;  July 2, 2007 ;     700+ words ... ... duration and clinical utility of Organon's FSH-CTP have already been demonstrated in previous clinical ... will be replicated in the clinical trials of our CTP-enhanced human growth hormone (hGH-CTP), interferon beta (IFN-Beta- CTP) and erythropoietin ...

Article: PROLOR Biotech Announces Initiation of Phase I Clinical Trial for ...
PR Newswire;  September 21, 2009 ;     700+ words ... ... Phase I clinical trial of its long-acting human growth hormone drug candidate hGH-CTP. hGH-CTP is being developed to provide growth hormone deficient adults and children with the option ...

Article: Modigene Awarded Second-Year Grant by Israeli Government to ...
PR Newswire;  January 27, 2009 ;     700+ words ... ... development program for hGH-CTP, its longer-acting version of human growth hormone (hGH). The new grant ... Modigene is using the same CTP technology to extend ... duration of action of human growth hormone and other therapeutic ... Washington University to the CTP technology for ...

Article: PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting ...
PR Newswire;  June 30, 2009 ;     700+ words ... ... patents for the company's long-acting CTP-enhanced human growth hormone (hGH-CTP) and human erythropoietin (EPO-CTP ... body. "These two new patents covering CTP-enhanced human growth hormone and erythropoietin represent another ...

Article: Modigene Awarded Israeli Government Grant to Support Development ...
PR Newswire;  November 27, 2007 ;     700+ words ... ... development program for hGH-CTP, its longer-acting version of human growth hormone (hGH). In preclinical ... single injection of hGH-CTP has shown the potential ... clinical trials. hGH-CTP is currently in preclinical ... begin in 2008. Human growth hormone is a natural protein ...

Article: Modigene Financing Garners $11.6M; High Hopes For CTP.
BIOWORLD Today;  May 16, 2007 ;     700+ words ... ... So far, Modigene has tested CTP-modified hGH and erythropoietin ... have shown interferon-beta-CTP has bioactivity similar to that ... beta. A longer-lasting growth hormone could help Modigene seize a ... the $2.2 billion market. CTP might create a better Aranesp ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives